Abstract
The European Group on Graves’ Orbitopathy (EUGOGO) recommends the use of specialised multidisciplinary clinics for the management of thyroid eye disease (TED). In the UK, many patients with TED are managed outside of specialised clinics. We describe the organisation of a combined TED clinic in a secondary care setting and present the result of a prospective audit of the patient characteristics and outcomes during the first four years of a combined TED clinic. Of a total of 132 patients referred to the TED clinic, 114 (86 %) had TED (90 females, median age 56 years; range 17–90 years). At presentation, 77 (67 %) were current or ex-smokers and 99 (87 %) were biochemically euthyroid. Median duration of eye symptoms was 12 months. Fifty-two percent, 45 and 3 had mild, moderate-to-severe and sight-threatening TED, respectively. Only 18 % of patients had a clinical activity score (CAS) of ≥3. Sixty-nine patients (61 %) required follow-up appointments in the TED clinic. In those who required follow-up, 43 % (n = 30) received either immunosuppressive or surgical treatment. CAS improved from first to final visit, with 29 % (n = 20) having a CAS of ≥3 at the first visit and 1 % (n = 1) at the final visit (p = 0.0001). There was also a decrease in prevalence of smoking and thyroid dysfunction at the final visit. A multidisciplinary specialised TED clinic offers an optimal setting for managing patients with TED; however, patients are often referred late to a specialist TED clinic.
Similar content being viewed by others
References
Bartalena L, Tanda ML (2009) Clinical practice. Graves’ ophthalmopathy. N Engl J Med 360:994–1001
Perros P, Neoh C, Dickinson J (2009) Thyroid eye disease. BMJ 338:b560
Perros P, Baldeschi L, Boboridis K, Dickinsom AJ, Hulo A, Kahaly GJ et al (2006) A questionnaire survey on the management of Graves’ orbitopathy in Europe. Eur J Endocrinol 155:207–211
Prummel MF, Bakker A, Wiersinga WM, Baldeschi L, Mourtis MP, Kendall-Taylor P et al (2003) Multi-center study on the characteristics and treatment strategies of patients with Graves’ orbitopathy: the first European Group on Graves’ Orbitopathy experience. Eur J Endocrinol 148:491–495
Wiersinga WM (2007) Management of Graves’ ophthalmopathy. Nat Clin Pract Endocrinol Metab 3:396–404
Estcourt S, Hickey J, Perros P, Dayan C, Vaidya B (2009) The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey. Eur J Endocrinol 161:483–487
Bartalena L, Baldeschi L, Dickinson A, Eckstein A, Kendall-Taylor P, Marcocci C, European Group on Graves’ Orbitopathy (EUGOGO) et al (2008) Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 158:273–285
Sasim IV, Berendschot TT, van Isterdael C, Mourtis MP (2008) Planning health care for patients with Graves’ orbitopathy. Graefes Arch Clin Exp Ophthalmol 246:1315–1321
http://eugogo.eu/clinical_evaluation.php. Accessed 19 Nov 2012
Mourits MP, Prummel MF, Wiersinga WM, Koornneef L (1997) Clinical activity score as a guide in the management of patients with Graves’ ophthalmopathy. Clin Endocrinol (Oxf) 47:9–14
Perros P, Crombie AL, Matthews JN, Kendall-Taylor P (1993) Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic. Clin Endocrinol (Oxf) 38:367–372
Perros P, Wiersinga WM (2010) The Amsterdam Declaration on Graves’ orbitopathy. Thyroid 20:245–246
Estcourt S, Vaidya B, Quinn A, Shepherd M (2008) The impact of thyroid eye disease upon patients’ wellbeing: a qualitative analysis. Clin Endocrinol (Oxf) 68:635–639
Perros P, Crombie AL, Kendall-Taylor P (1995) Natural history of thyroid associated ophthalmopathy. Clin Endocrinol (Oxf) 42:45–50
Conflict of interest
The authors report no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Benzimra, J.D., Quinn, A.G., Kersey, T. et al. Management of patients in a combined thyroid eye clinic in secondary care. Int Ophthalmol 34, 1–6 (2014). https://doi.org/10.1007/s10792-013-9768-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-013-9768-9